Combination therapy of ursodeoxycholic acid and glucocorticoid and (or) immunosuppressant in patients with primary biliary cholangitis: A meta-analysis

BACKGROUND/OBJECTIVES: Primary biliary cholangitis (PBC) is a chronic inflammatory autoimmune cholestasis liver disease. There were many studies comparing a combination of glucocorticoids and/or immunosuppressants to a single UDCA therapy in PBC patients, while the literature demonstrated divergent...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zi-Long, Song, Kai-Min, Jin, Rui, Xie, Yan-Di, Wang, Yu-Qiong, Liu, Zhi-Cheng, Feng, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896518/
https://www.ncbi.nlm.nih.gov/pubmed/35244071
http://dx.doi.org/10.1097/MD.0000000000028987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896518/
https://www.ncbi.nlm.nih.gov/pubmed/35244071
http://dx.doi.org/10.1097/MD.0000000000028987

Ejemplares similares